Centrient Pharmaceuticals on Monday started operation at its new dedicated manufacturing unit at Toansa in Punjab with an objective to scale up production capacity of statins in India.
“With doubling of our production capacity, we demonstrate our commitment to maintain our leadership position in line with our strategy and to continue supporting our customers’ business growth. Guided by our brand promise of Quality, Reliability and Sustainability, Centrient’s Rosuvastatin and Atorvastatin offer superior performance in all three areas to benefit of our customers and the environment,” said Frans Vlaar, the Chief Commercial Officer at Centrient.
Statins are currently the most prescribed drug class globally for the treatment of high cholesterol and cardiovascular diseases and are among the top-selling drugs worldwide.
Antibiotic use has surged globally, leading to a rise in antibiotic resistance, especially concerning in…
Choking is a leading cause of injury and death in young children, particularly those under…
Hard Water (Khara Pani) Leading To Hair Fall Hard water is rich in minerals and…
Discover how the rise in high blood pressure during pregnancy is impacting maternal and fetal…
"Discover the transformative power of six delicious homemade drinks that can help you naturally melt…
"Transform your weight loss routine with these eight delicious fat-flushing drinks that not only hydrate…